Home » Topics » Regulatory » Patents

Patents
RSS

Pierre Fabre discloses anticancer flavagline derivatives

Jan. 19, 2016

Incyte patents KDM1A inhibitors

Jan. 19, 2016

Lupin reports development of PI3K inhibitors

Jan. 18, 2016

Pfizer presents PI3Kalpha inhibitors

Jan. 18, 2016

Novartis develops sGC activators

Jan. 18, 2016

Pharmacyclics describes BTK inhibitors

Jan. 18, 2016

Hinova Pharmaceuticals patents potential treatments for gout

Jan. 18, 2016

Bayer Schering Pharma announces BUB1 inhibitors

Jan. 15, 2016

Katholieke Universiteit Leuven and UCB present PI4KIII-beta inhibitors

Jan. 15, 2016

UNAM discloses antidepressants from Casimiroa pubescens

Jan. 15, 2016

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...